Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Satiety

Satiety
2001 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of minimally invasive devices intended to treat obesity and certain other gastrointestinal conditions. The company's devices use a set of flexible staplers that is introduced trans orally to restrict the size of the stomach that gives patients a feeling of fullness after a small meal and eliminate many of the risks of conventional obesity surgery as it is incision less, does not transect the GI tract and does not involve an implant, enabling patients to reduce their weight.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 2470 Embarcadero Way
  • Palo Alto, CA 94303
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Satiety’s full profile, request a free trial.

Satiety Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Jan-2011 000.00 Completed Generating Revenue
6. Later Stage VC (Series E) 25-Sep-2009 000.00 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series D) 17-Jul-2007 000.00 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series C) 20-Jun-2005 00.000 000.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 03-Jan-2003 0000 0000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 11-May-2001 $4M $4M 0000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Satiety Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.00
Series D 00,000,000 00.000000 00.00 00.0 00.0 00 00.00 00.000
Series C 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
Series B 8,500,000 $0.001000 $0.12 $1.5 $1.5 1x $1.5 11.4%
Series A 4,000,000 $0.001000 $0.08 $1 $1 1x $1 5.37%
To view this company’s complete Cap Table, request access »

Satiety Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ABS Ventures Venture Capital Minority 000 0000 000000 0
Emergent Medical Partners Venture Capital Minority 000 0000 000000 0
HLM Venture Partners Venture Capital Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
Kearny Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Satiety Executive Team (3)

Name Title Board
Seat
Contact
Info
James Scott Vice President
John Gaiser Vice President, Research & Development

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »